A Phase II Trial of Cetuximab in Unresectable or Metastatic Esophageal and Gastric Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 21 May 2015
At a glance
- Drugs Cetuximab (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Feb 2012 Actual patient number (38) added as reported by ClinicalTrials.gov.
- 22 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.